Summary

Eligibility
for people ages 18 years and up (full criteria)
Healthy Volunteers
healthy people welcome
Location
at UCLA
Dates
study started
estimated completion
Principal Investigator
by Victor W. Nitti, MD (ucla)

Description

Summary

In this study, the investigators aim to validate the telemedicine paradigm as a feasible alternative to traditional in-person clinic visits for the management of overactive bladder (OAB).

Official Title

A Prospective Study Evaluating the Feasibility of Telemedicine Use in the Overactive Bladder Clinical Care Pathway: a Non-inferiority Study Assessing Patient Satisfaction and Progression to Third Line Overactive Bladder Therapies

Details

This is a single-center, prospective randomized controlled trial. The study population will consist of two primary cohorts stratified based on the method of follow-up, either traditional in-person clinic visit or telemedicine appointment. The primary outcome will be satisfaction with OAB treatment. Secondary endpoints include rate of progression to third line therapies, changes in OAB symptom scores, safety, and cost. This non-inferiority trial is designed to provide an alternative option for care delivery that may result in improved patient satisfaction and compliance, and decreased cost, time, and travel burden for patients.

Keywords

Overactive Bladder Urinary Bladder, Overactive SUFU Clinical Care Pathway for Overactive Bladder Telemedicine

Eligibility

You can join if…

Open to people ages 18 years and up

  • Idiopathic overactive bladder diagnosis, both OAB wet and OAB dry

You CAN'T join if...

  • Active Urinary Tract Infection (UTI)
  • Stage 3 or 4 prolapse
  • Underlying neurologic condition contributing to OAB
  • Use of catheter

Location

  • UCLA accepting new patients
    Los Angeles California 90095 United States

Lead Scientist at University of California Health

  • Victor W. Nitti, MD (ucla)
    Professor, Urology. Authored (or co-authored) 317 research publications.

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, Los Angeles
ID
NCT05117918
Study Type
Interventional
Last Updated